- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Multiple sclerosis (MS)
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1360KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 165KB)
Siponimod – July 2020
Siponimod: Tablet 250 micrograms, Tablet 2 mg; Mayzent®
Last updated
30 October 2020